| Year |
Citation |
Score |
| 2023 |
Chirokoff V, Dupuy M, Abdallah M, Fatseas M, Serre F, Auriacombe M, Misdrahi D, Berthoz S, Swendsen J, Sullivan EV, Chanraud S. Craving dynamics and related cerebral substrates predict timing of use in alcohol, tobacco, and cannabis use disorders. Addiction Neuroscience. 9. PMID 38389954 DOI: 10.1016/j.addicn.2023.100138 |
0.619 |
|
| 2023 |
Chapron SA, Kervran C, Da Rosa M, Fournet L, Shmulewitz D, Hasin D, Denis C, Collombat J, Monsaingeon M, Fatseas M, Gatta-Cherifi B, Serre F, Auriacombe M. Does food use disorder exist? Item response theory analyses of a food use disorder adapted from the DSM-5 substance use disorder criteria in a treatment seeking clinical sample. Drug and Alcohol Dependence. 251: 110937. PMID 37666092 DOI: 10.1016/j.drugalcdep.2023.110937 |
0.784 |
|
| 2022 |
Morawetz C, Berboth S, Chirokoff V, Chanraud S, Misdrahi D, Serre F, Auriacombe M, Fatseas M, Swendsen J. Mood Variability, Craving, and Substance Use Disorders: From Intrinsic Brain Network Connectivity to Daily Life Experience. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 36775712 DOI: 10.1016/j.bpsc.2022.11.002 |
0.744 |
|
| 2022 |
Jakubiec L, Chirokoff V, Abdallah M, Sanz-Arigita E, Dupuy M, Swendsen J, Berthoz S, Gierski F, Guionnet S, Misdrahi D, Serre F, Auriacombe M, Fatseas M. The Executive Functioning Paradox in Substance Use Disorders. Biomedicines. 10. PMID 36359247 DOI: 10.3390/biomedicines10112728 |
0.771 |
|
| 2022 |
Jean FAM, Arsandaux J, Montagni I, Collet O, Fatséas M, Auriacombe M, Ramos-Quiroga JA, Côté SM, Tzourio C, Galéra C. Attention deficit hyperactivity disorder symptoms and cannabis use after one year among students of the i-Share cohort. European Psychiatry : the Journal of the Association of European Psychiatrists. 1-18. PMID 35348052 DOI: 10.1192/j.eurpsy.2022.14 |
0.54 |
|
| 2021 |
Dupuy M, Abdallah M, Swendsen J, N'Kaoua B, Chanraud S, Schweitzer P, Fatseas M, Serre F, Barse E, Auriacombe M, Misdrahi D. Real-time cognitive performance and positive symptom expression in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. PMID 34287696 DOI: 10.1007/s00406-021-01296-2 |
0.709 |
|
| 2019 |
Benchebra L, Alexandre JM, Dubernet J, Fatséas M, Auriacombe M. [Gambling and Gaming disorders and physical health of players: A critical review of the literature]. Presse Medicale (Paris, France : 1983). PMID 31767247 DOI: 10.1016/J.Lpm.2019.10.014 |
0.575 |
|
| 2019 |
Leouzon H, Alexandre J, Fatséas M, Auriacombe M. L’addiction aux jeux vidéo dans le DSM-5, controverses et réponses relatives à son diagnostic et sa définition Annales MéDico-Psychologiques, Revue Psychiatrique. 177: 610-623. DOI: 10.1016/J.Amp.2019.03.013 |
0.562 |
|
| 2018 |
Auriacombe M, Moriceau S, Serre F, Denis C, Micoulaud-Franchi JA, de Sevin E, Bonhomme E, Bioulac S, Fatseas M, Philip P. Development and validation of a virtual agent to screen tobacco and alcohol use disorders. Drug and Alcohol Dependence. 193: 1-6. PMID 30321739 DOI: 10.1016/J.Drugalcdep.2018.08.025 |
0.8 |
|
| 2018 |
Bouvard A, Dupuy M, Schweitzer P, Revranche M, Fatseas M, Serre F, Misdrahi D, Auriacombe M, Swendsen J. Feasibility and validity of mobile cognitive testing in patients with substance use disorders and healthy controls. The American Journal On Addictions. 27: 553-556. PMID 30260085 DOI: 10.1111/Ajad.12804 |
0.764 |
|
| 2018 |
Fatseas M, Serre F, Swendsen J, Auriacombe M. Effects of anxiety and mood disorders on craving and substance use among patients with substance use disorder: An ecological momentary assessment study. Drug and Alcohol Dependence. 187: 242-248. PMID 29684892 DOI: 10.1016/J.Drugalcdep.2018.03.008 |
0.784 |
|
| 2018 |
Serre F, Fatseas M, Denis C, Swendsen J, Auriacombe M. Predictors of craving and substance use among patients with alcohol, tobacco, cannabis or opiate addictions: Commonalities and specificities across substances. Addictive Behaviors. PMID 29428330 DOI: 10.1016/J.Addbeh.2018.01.041 |
0.81 |
|
| 2018 |
Dupuy M, Misdrahi D, N’Kaoua B, Tessier A, Bouvard A, Schweitzer P, Auriacombe M, Serre F, Fatseas M, Swendsen J. Mobile cognitive testing in patients with schizophrenia: A controlled study of feasibility and validity Journal De ThéRapie Comportementale Et Cognitive. 28: 204-213. DOI: 10.1016/J.Jtcc.2018.02.002 |
0.738 |
|
| 2018 |
Auriacombe M, Fatséas M, Daulouède J, Tignol J. Le craving et nouvelle clinique de l’addiction : une perspective simplifiée et opérationnelle Annales MéDico-Psychologiques, Revue Psychiatrique. 176: 746-749. DOI: 10.1016/J.Amp.2018.08.014 |
0.53 |
|
| 2017 |
Dupouy J, Palmaro A, Fatséas M, Auriacombe M, Micallef J, Oustric S, Lapeyre-Mestre M. Mortality Associated With Time in and Out of Buprenorphine Treatment in French Office-Based General Practice: A 7-Year Cohort Study. Annals of Family Medicine. 15: 355-358. PMID 28694272 DOI: 10.1370/Afm.2098 |
0.57 |
|
| 2017 |
Gorsane MA, Reynaud M, Vénisse JL, Legauffre C, Valleur M, Magalon D, Fatséas M, Chéreau-Boudet I, Guilleux A, Challet-Bouju G, Grall-Bronnec M. Gambling disorder-related illegal acts: Regression model of associated factors. Journal of Behavioral Addictions. 1-10. PMID 28198636 DOI: 10.1556/2006.6.2017.003 |
0.401 |
|
| 2017 |
Bouvard A, Dupuy M, Chevalier M, Jakubiec L, Fatseas M, Serre F, Hurmic H, Revranche M, Misdrahi D, Auriacombe M, Swendsen J. Feasibility and validity of mobile cognitive testing in patients with substance use disorders European Neuropsychopharmacology. 27. DOI: 10.1016/S0924-977X(17)31890-4 |
0.764 |
|
| 2017 |
Dupouy J, Palmaro A, Fatséas M, Auriacombe M, Micallef J, Oustric S, Lapeyre-Mestre M. Mortalité associée aux périodes sous et hors traitement par buprénorphine Therapies. 72: 164. DOI: 10.1016/J.Therap.2016.11.041 |
0.539 |
|
| 2017 |
Techer L, Alexandre J, Mété D, Auriacombe M, Fatseas M. Addictive behaviors and psychiatric comorbidities of incarcerated women in a French overseas territory Drug and Alcohol Dependence. 171: e201. DOI: 10.1016/J.Drugalcdep.2016.08.549 |
0.556 |
|
| 2017 |
Serre F, Fatseas M, Swendsen J, Auriacombe M. How psychiatric comorbidity and mood states influence craving and substance use in daily life? An ecological momentary assessment study in patients with alcohol, tobacco, cannabis and heroin use disorders Drug and Alcohol Dependence. 171: e187. DOI: 10.1016/J.Drugalcdep.2016.08.513 |
0.788 |
|
| 2017 |
Fatseas M, Henry M, da Rosa MAC, Collombat J, Gregoire A, Kervran C, Cherifi B, Auriacombe M. Eating disorder, food addiction and associated factors in obese patients Drug and Alcohol Dependence. 171: e62. DOI: 10.1016/J.Drugalcdep.2016.08.180 |
0.58 |
|
| 2017 |
Denis CM, da Rosa MAC, Serre F, Kervran C, Henry M, Cherifi B, Auriacombe M, Fatseas M. Are DSM-5 criteria for sud transferable to food addiction? IRT analysis for alcohol, tobacco, cannabis, opiate and food addiction in a clinical sample Drug and Alcohol Dependence. 171: e52. DOI: 10.1016/J.Drugalcdep.2016.08.155 |
0.734 |
|
| 2017 |
Auriacombe M, Alexandre J, Dubernet J, Tanguy J, Fatseas M. Contribution of e-learning to addiction teaching: A successful experience at the university of bordeaux, France Drug and Alcohol Dependence. 171: e12. DOI: 10.1016/J.Drugalcdep.2016.08.048 |
0.508 |
|
| 2016 |
Fatséas M, Hurmic H, Serre F, Debrabant R, Daulouède JP, Denis C, Auriacombe M. Addiction severity pattern associated with adult and childhood Attention Deficit Hyperactivity Disorder (ADHD) in patients with addictions. Psychiatry Research. PMID 27842945 DOI: 10.1016/J.Psychres.2016.10.071 |
0.803 |
|
| 2016 |
Konstenius M, Leifman A, van Emmerik-van Oortmerssen K, van de Glind G, Franck J, Moggi F, Ramos-Quiroga JA, Levin FR, Carpentier PJ, Skutle A, Bu ET, Kaye S, Demetrovics Z, Barta C, Auriecomb M, et al. Childhood trauma exposure in substance use disorder patients with and without ADHD. Addictive Behaviors. 65: 118-124. PMID 27816036 DOI: 10.1016/J.Addbeh.2016.10.016 |
0.34 |
|
| 2016 |
Romo L, Legauffre C, Guilleux A, Valleur M, Magalon D, Fatséas M, Chéreau-Boudet I, Luquiens A, Vénisse JL, Grall-Bronnec M, Challet-Bouju G. Cognitive distortions and ADHD in pathological gambling: A national longitudinal case-control cohort study. Journal of Behavioral Addictions. 5: 649-657. PMID 27774813 DOI: 10.1556/2006.5.2016.070 |
0.355 |
|
| 2016 |
Fatseas M, Alexandre JM, Vénisse JL, Romo L, Valleur M, Magalon D, Chéreau-Boudet I, Luquiens A, Guilleux A, Groupe Jeu, Challet-Bouju G, Grall-Bronnec M. Gambling behaviors and psychopathology related to Attention-Deficit/Hyperactivity Disorder (ADHD) in problem and non-problem adult gamblers. Psychiatry Research. 239: 232-8. PMID 27031593 DOI: 10.1016/J.Psychres.2016.03.028 |
0.333 |
|
| 2016 |
Fatseas M, Kervran C, Auriacombe M. [Sleep disorders and addictions: Impact on quality of life and relapse vulnerability]. Presse Medicale (Paris, France : 1983). 45: 1164-1169. PMID 26970937 DOI: 10.1016/J.Lpm.2016.01.022 |
0.583 |
|
| 2016 |
Kaye S, Ramos-Quiroga JA, van de Glind G, Levin FR, Faraone SV, Allsop S, Degenhardt L, Moggi F, Barta C, Konstenius M, Franck J, Skutle A, Bu ET, Koeter MW, Demetrovics Z, et al. Persistence and Subtype Stability of ADHD Among Substance Use Disorder Treatment Seekers. Journal of Attention Disorders. PMID 26922805 DOI: 10.1177/1087054716629217 |
0.625 |
|
| 2016 |
Denis C, Fatséas M, Beltran V, Serre F, Alexandre JM, Debrabant R, Daulouède JP, Auriacombe M. Usefulness and validity of the modified Addiction Severity Index: A focus on alcohol, drugs, tobacco, and gambling. Substance Abuse. 37: 168-75. PMID 26110463 DOI: 10.1080/08897077.2015.1036334 |
0.825 |
|
| 2016 |
Denis C, Fatséas M, Beltran V, Serre F, Alexandre JM, Debrabant R, Daulouède JP, Auriacombe M. Usefulness and validity of the modified Addiction Severity Index: A focus on alcohol, drugs, tobacco, and gambling Substance Abuse. 37: 168-175. DOI: 10.1080/08897077.2015.1036334 |
0.778 |
|
| 2016 |
Auriacombe M, Debrabant R, Kervran C, Serre F, Taillard J, Philip P, Denis C, Fatséas M. Addiction et troubles du sommeil : craving, rythmes circadiens. Une mise au point MéDecine Du Sommeil. 13: 91-99. DOI: 10.1016/J.Msom.2016.04.004 |
0.759 |
|
| 2015 |
Skutle A, Bu ETH, Jellestad FK, van Emmerik-van Oortmerssen K, Dom G, Verspreet S, Carpentier PJ, Ramos-Quiroga JA, Franck J, Konstenius M, Kaye S, Demetrovics Z, Barta C, Fatséas M, Auriacombe M, et al. Early developmental, temperamental and educational problems in 'substance use disorder' patients with and without ADHD. Does ADHD make a difference? Addictive Behaviors Reports. 2: 13-18. PMID 29531989 DOI: 10.1016/J.Abrep.2015.03.001 |
0.595 |
|
| 2015 |
Kervran C, Fatséas M, Serre F, Taillard J, Beltran V, Leboucher J, Debrabant R, Alexandre JM, Daulouède JP, Philip P, Auriacombe M. Association between morningness/eveningness, addiction severity and psychiatric disorders among individuals with addictions. Psychiatry Research. 229: 1024-30. PMID 26250146 DOI: 10.1016/J.Psychres.2015.05.026 |
0.78 |
|
| 2015 |
Wapp M, van de Glind G, van Emmerik-van Oortmerssen K, Dom G, Verspreet S, Carpentier PJ, Ramos-Quiroga JA, Skutle A, Bu ET, Franck J, Konstenius M, Kaye S, Demetrovics Z, Barta C, Fatséas M, et al. Risk Factors for Borderline Personality Disorder in Treatment Seeking Patients with a Substance Use Disorder: An International Multicenter Study. European Addiction Research. 21: 188-94. PMID 25832736 DOI: 10.1159/000371724 |
0.622 |
|
| 2015 |
Fatseas M, Serre F, Alexandre JM, Debrabant R, Auriacombe M, Swendsen J. Craving and substance use among patients with alcohol, tobacco, cannabis or heroin addiction: a comparison of substance- and person-specific cues. Addiction (Abingdon, England). 110: 1035-42. PMID 25688760 DOI: 10.1111/Add.12882 |
0.772 |
|
| 2015 |
Serre F, Fatseas M, Swendsen J, Auriacombe M. Ecological momentary assessment in the investigation of craving and substance use in daily life: a systematic review. Drug and Alcohol Dependence. 148: 1-20. PMID 25637078 DOI: 10.1016/J.Drugalcdep.2014.12.024 |
0.774 |
|
| 2015 |
Challet-Bouju G, Hardouin JB, Renard N, Legauffre C, Valleur M, Magalon D, Fatséas M, Chéreau-Boudet I, Gorsane MA, Vénisse JL, Grall-Bronnec M. A Gamblers Clustering Based on Their Favorite Gambling Activity. Journal of Gambling Studies. 31: 1767-88. PMID 25192752 DOI: 10.1007/S10899-014-9496-8 |
0.322 |
|
| 2015 |
Demaret I, Quertemont E, Litran G, Magoga C, Deblire C, Auriacombe M, Dubois N, Roubaix JD, Charlier C, Lemaître A, Ansseau M, Senbanjo R, Strang J, Fernández-Aranda F, Jiménez-Murcia S, et al. Front & Back Matter European Addiction Research. 21. DOI: 10.1159/000342515 |
0.497 |
|
| 2015 |
Auriacombe M, Denis CM, Rosa MAC, Collombat J, Serre F, Daulouede J, Fatseas M. Validity of the eating section for the modified addiction severity index Drug and Alcohol Dependence. 156: e12. DOI: 10.1016/J.Drugalcdep.2015.07.951 |
0.727 |
|
| 2015 |
Serre F, Fatseas M, Swendsen J, Auriacombe M. Does craving intensity influence cue exposure reports? An ecological momentary assessment study in patients with alcohol, tobacco, cannabis and heroin use disorder Drug and Alcohol Dependence. 156: e201. DOI: 10.1016/J.Drugalcdep.2015.07.542 |
0.775 |
|
| 2015 |
Rosa MAC, Collombat J, Denis CM, Alexandre J, Serre F, Auriacombe M, Fatseas M. Overlap between food addiction and DSM-5 eating disorders in a treatment seeking sample Drug and Alcohol Dependence. 156: e192. DOI: 10.1016/J.Drugalcdep.2015.07.517 |
0.773 |
|
| 2015 |
Lhommeau N, Alexandre J, Mete D, Fatseas M, Auriacombe M. Characteristics of gamblers choosing self-exclusion from casinos: A prospective study in a French overseas territory Drug and Alcohol Dependence. 156: e127. DOI: 10.1016/J.Drugalcdep.2015.07.350 |
0.525 |
|
| 2015 |
Hurmic H, Debrabant R, Kervran C, Serre F, Auriacombe M, Fatseas M. ADHD and substance use disorders: Subtype and gender differences Drug and Alcohol Dependence. 156: e100-e101. DOI: 10.1016/J.Drugalcdep.2015.07.1190 |
0.764 |
|
| 2015 |
Fatseas M, Collombat J, Rosa MAC, Denis CM, Alexandre J, Debrabant R, Serre F, Auriacombe M. Measuring “craving” in food addiction: Type, frequency, intensity Drug and Alcohol Dependence. 156: e66. DOI: 10.1016/J.Drugalcdep.2015.07.1099 |
0.711 |
|
| 2015 |
Serre F, Fatseas M, Swendsen J, Auriacombe M. Corrigendum to “Ecological momentary assessment in the investigation of craving and substance use in daily life: A systematic review” Drug and Alcohol Dependence 148 (2015) 1–20 Drug and Alcohol Dependence. 154: 305-314. DOI: 10.1016/J.Drugalcdep.2015.03.001 |
0.777 |
|
| 2015 |
Serre F, Fatseas M, Swendsen J, Auriacombe M. Are sleep disturbances associated with craving intensity? What is the influence of psychiatric comorbidity and type of substance on this relationship? A computerized ambulatory monitoring study in patients beginning treatment for addiction Drug and Alcohol Dependence. 146: e94. DOI: 10.1016/J.Drugalcdep.2014.09.623 |
0.748 |
|
| 2015 |
Kervran C, Serre F, Fatseas M, Debrabant R, Trouba C, Taillard J, Philip P, Auriacombe M. Sleep quality in patients with SUD and behavioral addictions assessed by actigraphy: A prospective study Drug and Alcohol Dependence. 146: e156-e157. DOI: 10.1016/J.Drugalcdep.2014.09.343 |
0.724 |
|
| 2015 |
Hurmic H, Debrabant R, Serre F, Fatseas M, Alix M, Auriacombe M. Frequency and intensity of craving among addicted patients during outpatient treatment Drug and Alcohol Dependence. 146: e145. DOI: 10.1016/J.Drugalcdep.2014.09.312 |
0.734 |
|
| 2015 |
Fatseas M, Hurmic H, Debrabant R, Serre F, Auriacombe M. Substance use patterns associated with adult ADHD in SUD treatment-seeking patients: Results from the aquitaine addiction cohort study Drug and Alcohol Dependence. 146: e274-e275. DOI: 10.1016/J.Drugalcdep.2014.09.213 |
0.757 |
|
| 2015 |
Denis CM, Fatseas M, Beltran V, Daulouede J, Auriacombe M. Impact of 20 years harm reduction policy on HIV and HCV among opioid users not in treatment Drug and Alcohol Dependence. 146: e261. DOI: 10.1016/J.Drugalcdep.2014.09.177 |
0.538 |
|
| 2015 |
Daulouède J, Denis CM, Fatseas M, Beltran V, Auriacombe M. Risk-taking behavior over 36-month follow-up treatment in outpatient opioid maintenance treatment program Drug and Alcohol Dependence. 146: e258. DOI: 10.1016/J.Drugalcdep.2014.09.168 |
0.552 |
|
| 2015 |
Alexandre J, Fatseas M, Bouju G, Legauffre C, Valleur M, Magalon D, Chereau-Boudet I, Gorsane M, Auriacombe M, Hardouin J, Venisse J, Grall-Bronnec M. Gambling behavior among gamblers with and without attention deficit/hyperactivity disorder Drug and Alcohol Dependence. 146: e205-e206. DOI: 10.1016/J.Drugalcdep.2014.09.027 |
0.585 |
|
| 2015 |
Skutle A, Bu ETH, Jellestad FK, van Emmerik-van Oortmerssen K, Dom G, Verspreet S, Carpentier PJ, Ramos-Quiroga JA, Franck J, Konstenius M, Kaye S, Demetrovics Z, Barta C, Fatséas M, Auriacombe M, et al. Early developmental, temperamental and educational problems in 'substance use disorder' patients with and without ADHD: Does ADHD make a difference? Addictive Behaviors Reports. 2: 13-18. DOI: 10.1016/j.abrep.2015.03.001 |
0.55 |
|
| 2014 |
Auriacombe M, Denis C, Fatséas M. Commentary on Scharkow etal. (2014): Welcomed and yet to come. Are we looking at what we are looking for? Addiction. 109: 1918-1919. PMID 25297961 DOI: 10.1111/Add.12723 |
0.638 |
|
| 2014 |
Lofwall MR, Martin J, Tierney M, Fatséas M, Auriacombe M, Lintzeris N. Buprenorphine diversion and misuse in outpatient practice. Journal of Addiction Medicine. 8: 327-32. PMID 25221985 DOI: 10.1097/Adm.0000000000000029 |
0.554 |
|
| 2014 |
van Emmerik-van Oortmerssen K, van de Glind G, Koeter MW, Allsop S, Auriacombe M, Barta C, Bu ET, Burren Y, Carpentier PJ, Carruthers S, Casas M, Demetrovics Z, Dom G, Faraone SV, Fatseas M, et al. Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study. Addiction (Abingdon, England). 109: 262-72. PMID 24118292 DOI: 10.1111/Add.12370 |
0.636 |
|
| 2014 |
Debrabant R, Fatseas M, Denis C, Taillard J, Philip P, Auriacombe M. Qualité subjective du sommeil chez des sujets dépendants aux opiacés traités par méthadone ou buprénorphine MéDecine Du Sommeil. 11: 34-35. DOI: 10.1016/J.Msom.2014.01.082 |
0.643 |
|
| 2014 |
Serre F, Fatseas M, Swendsen J, Taillard J, Philip P, Auriacombe M. Relation entre problèmes de sommeil et envie de consommer (craving) chez des sujets dépendants en début de prise en charge pour leur addiction MéDecine Du Sommeil. 11: 34. DOI: 10.1016/J.Msom.2014.01.081 |
0.714 |
|
| 2014 |
Swendsen J, Serre F, Fatseas M, Auriacombe M. A systematic review of studies exploring craving, its moderators, and the link with substance use in daily life using Ecological Momentary Assessment (EMA) Drug and Alcohol Dependence. 140: e221. DOI: 10.1016/J.Drugalcdep.2014.02.613 |
0.776 |
|
| 2014 |
Serre F, Fatseas M, Swendsen J, Auriacombe M. Does craving predict substance use for different substance use disorders? An ecological momentary assessment study in patients with alcohol, tobacco, cannabis and heroin dependence Drug and Alcohol Dependence. 140: e202-e203. DOI: 10.1016/J.Drugalcdep.2014.02.564 |
0.786 |
|
| 2014 |
Fatseas M, Serre F, Swendsen J, Auriacombe M. Does cue type matter for craving? Comparison of substance-specific and person-specific cues using mobile technologies Drug and Alcohol Dependence. 140: e57. DOI: 10.1016/J.Drugalcdep.2014.02.175 |
0.723 |
|
| 2014 |
Auriacombe M, Denis CM, Beltran V, Alexandre J, Debrabant R, Serre F, Daulouede J, Fatseas M. 10-years outcome of methadone- and buprenorphine-maintained patients. Mortality, quality of life and substance use Drug and Alcohol Dependence. 140: e8. DOI: 10.1016/J.Drugalcdep.2014.02.043 |
0.743 |
|
| 2013 |
van de Glind G, Van Emmerik-van Oortmerssen K, Carpentier PJ, Levin FR, Koeter MW, Barta C, Kaye S, Skutle A, Franck J, Konstenius M, Bu ET, Moggi F, Dom G, Demetrovics Z, Fatséas M, et al. The International ADHD in Substance Use Disorders Prevalence (IASP) study: background, methods and study population. International Journal of Methods in Psychiatric Research. 22: 232-44. PMID 24022983 DOI: 10.1002/Mpr.1397 |
0.359 |
|
| 2013 |
Denis C, Lavie E, Fatseas M, Auriacombe M. WITHDRAWN: Psychotherapeutic interventions for cannabis abuse and/or dependence in outpatient settings The Cochrane Database of Systematic Reviews. 6. PMID 23780682 |
0.77 |
|
| 2013 |
Denis C, Fatseas M, Lavie E, Auriacombe M. WITHDRAWN: Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings The Cochrane Database of Systematic Reviews. 6. PMID 23780681 DOI: 10.1002/14651858.Cd005194.Pub3 |
0.76 |
|
| 2012 |
Bosc E, Fatséas M, Alexandre JM, Auriacombe M. [Similarities and differences between pathological gambling and substance dependance: A clarification]. L'Encephale. 38: 433-9. PMID 23062458 DOI: 10.1016/J.Encep.2012.02.004 |
0.571 |
|
| 2012 |
Serre F, Fatseas M, Debrabant R, Alexandre JM, Auriacombe M, Swendsen J. Ecological momentary assessment in alcohol, tobacco, cannabis and opiate dependence: a comparison of feasibility and validity. Drug and Alcohol Dependence. 126: 118-23. PMID 22647899 DOI: 10.1016/J.Drugalcdep.2012.04.025 |
0.763 |
|
| 2012 |
Fatseas M, Debrabant R, Auriacombe M. The diagnostic accuracy of attention-deficit/hyperactivity disorder in adults with substance use disorders. Current Opinion in Psychiatry. 25: 219-25. PMID 22449768 DOI: 10.1097/Yco.0B013E3283523D7C |
0.62 |
|
| 2012 |
Malivert M, Fatséas M, Denis C, Langlois E, Auriacombe M. Effectiveness of therapeutic communities: a systematic review. European Addiction Research. 18: 1-11. PMID 21997500 DOI: 10.1159/000331007 |
0.659 |
|
| 2012 |
Fatseas M, Denis C, Serre F, Dubernet J, Daulouède JP, Auriacombe M. Change in HIV-HCV risk-taking behavior and seroprevalence among opiate users seeking treatment over an 11-year period and harm reduction policy. Aids and Behavior. 16: 2082-90. PMID 21983799 DOI: 10.1007/S10461-011-0054-4 |
0.762 |
|
| 2012 |
Denis C, Fatséas M, Auriacombe M. Analyses related to the development of DSM-5 criteria for substance use related disorders: 3. An assessment of Pathological Gambling criteria Drug and Alcohol Dependence. 122: 22-27. PMID 21962725 DOI: 10.1016/J.Drugalcdep.2011.09.006 |
0.727 |
|
| 2011 |
Fatseas M, Denis C, Massida Z, Verger M, Franques-Rénéric P, Auriacombe M. Cue-induced reactivity, cortisol response and substance use outcome in treated heroin dependent individuals. Biological Psychiatry. 70: 720-7. PMID 21741031 DOI: 10.1016/J.Biopsych.2011.05.015 |
0.693 |
|
| 2011 |
Denis C, Langlois E, Fatséas M, Auriacombe M, Auriacombe PM. Un modèle français de Communauté Thérapeutique ? Les communautés thérapeutiques expérimentales : Consensus des professionnels Psychotropes. 17: 85. DOI: 10.3917/Psyt.173.0085 |
0.646 |
|
| 2010 |
Fatséas M, Denis C, Lavie E, Auriacombe M. Relationship between anxiety disorders and opiate dependence- A systematic review of the literature. Implications for diagnosis and treatment Journal of Substance Abuse Treatment. 38: 220-230. PMID 20116963 DOI: 10.1016/J.Jsat.2009.12.003 |
0.799 |
|
| 2009 |
Le Bec PY, Fatséas M, Denis C, Lavie E, Auriacombe M. [Cannabis and psychosis: search of a causal link through a critical and systematic review]. L'Encephale. 35: 377-85. PMID 19748375 DOI: 10.1016/J.Encep.2008.02.012 |
0.776 |
|
| 2009 |
Fatséas M, Lavie E, Denis C, Auriacombe M. Self-perceived motivation for benzodiazepine use and behavior related to benzodiazepine use among opiate-dependent patients Journal of Substance Abuse Treatment. 37: 407-411. PMID 19339146 DOI: 10.1016/J.Jsat.2009.03.006 |
0.783 |
|
| 2009 |
Lavie E, Fatséas M, Denis C, Auriacombe M. Benzodiazepine use among opiate-dependent subjects in buprenorphine maintenance treatment: Correlates of use, abuse and dependence Drug and Alcohol Dependence. 99: 338-344. PMID 18824311 DOI: 10.1016/J.Drugalcdep.2008.07.017 |
0.8 |
|
| 2008 |
Lavie E, Fatséas M, Daulouède JP, Denis C, Dubernet J, Cattan L, Auriacombe M. Comparison of prescriber evaluations and patient-directed self-reports in office-based practice for buprenorphine treatment of opiate-dependent individuals in France, 2002. Patient Preference and Adherence. 2: 369-78. PMID 19920984 DOI: 10.2147/Ppa.S4136 |
0.793 |
|
| 2007 |
Fatseas M, Auriacombe M. Why buprenorphine is so successful in treating opiate addiction in France. Current Psychiatry Reports. 9: 358-64. PMID 17915074 DOI: 10.1007/S11920-007-0046-2 |
0.56 |
|
| 2006 |
Denis C, Lavie E, Fatséas M, Auriacombe M. Psychotherapeutic interventions for cannabis abuse and/or dependence in outpatient settings Cochrane Database of Systematic Reviews (Online). 3. PMID 16856093 DOI: 10.1002/14651858.Cd005336.Pub2 |
0.799 |
|
| 2006 |
Denis C, Fatséas M, Lavie E, Auriacombe M. Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings. The Cochrane Database of Systematic Reviews. CD005194. PMID 16856084 DOI: 10.1002/14651858.CD005194.pub2 |
0.786 |
|
| 2006 |
Fatséas M, Lavie E, Denis C, Franques-Rénéric P, Tignol J, Auriacombe M. [Benzodiazepine withdrawal in subjects on opiate substitution treatment]. Presse Medicale (Paris, France : 1983). 35: 599-606. PMID 16614601 DOI: 10.1016/S0755-4982(06)74647-4 |
0.781 |
|
| 2005 |
Denis C, Fatseas M, Lavie E, Auriacombe M. Pharmacological interventions for benzodiazepine dependence management among benzodiazepine users in outpatient settings Cochrane Database of Systematic Reviews. DOI: 10.1002/14651858.Cd005194 |
0.744 |
|
| 2004 |
Auriacombe M, Fatséas M, Dubernet J, Daulouède JP, Tignol J. French field experience with buprenorphine. The American Journal On Addictions. 13: S17-28. PMID 15204673 DOI: 10.1080/10550490490440780 |
0.572 |
|
| 2004 |
Lavie E, Fatseas M, Messiah A, Franques P, Tignol J, Auriacombe M. P8-8 Facteurs associés à la consommation de benzodiazépines chez des patients traités par buprénorphine pour une dépendance aux opiacés (Aquitaine, France, 2001-2004) Revue D'éPidéMiologie Et De Santé Publique. 52: 109-110. DOI: 10.1016/S0398-7620(04)99304-2 |
0.721 |
|
| 2003 |
Auriacombe M, Fatseas M, Franques-Rénéric P, Daulouède JP, Tignol J. [Substitution therapy in drug addictions]. La Revue Du Praticien. 53: 1327-34. PMID 12920942 |
0.55 |
|
| Show low-probability matches. |